Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling

Journal of Vascular Surgery

Volumn 54, Issue 5, 2011, Pages 1383-1389

  Conte, Michael S ^a   Nugent, Helen M ^b   Gaccione, Peter ^b   Roy Chaudhury, Prabir ^c   Lawson, Jeffrey H ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Pervasis Therapeutics Inc   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ADULT; ALLOGENEIC AORTIC ENDOTHELIAL CELL IMPLANT; ALLOTRANSPLANTATION; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; GEL; HUMAN; IMPLANT; KIDNEY FAILURE; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; ULTRASOUND; VASCULAR ENDOTHELIUM; VASCULAR SURGERY; VEIN DIAMETER;

ADULT; AGED; ARTERIOVENOUS SHUNT, SURGICAL; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; FEMALE; GELATIN SPONGE, ABSORBABLE; GRAFT OCCLUSION, VASCULAR; HUMANS; HYPERPLASIA; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE SCAFFOLDS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; UNITED STATES; UPPER EXTREMITY; VASCULAR PATENCY; VEINS;

EID: 81155161949     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.05.005     Document Type: Article

References (36)

1. Vascular Access 2006 Work Group. NKF-KDOQI Clinical practice guidelines for vascular access.AmJ Kidney Dis 2006;48(Suppl 1):S176-247.
2. Lacson E Jr, Lazarus JM, Himmelfarb J, Ikizler TA, Hakim RM. Balancing fistula first with catheters last. Am J Kidney Dis 2007;50:379-95. (Pubitemid 47299270)
3. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008;299:2164-71. (Pubitemid 351679707)
4. Dixon BS. Why don't fistulas mature? Kidney Intl 2006;70:1413-22. (Pubitemid 44527310)
5. Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 2006;17:1112-27.
6. Ene-Iordache B, Mosconi L, Antiga L, Bruno S, Anghileri A, Remuzzi G, et al. Radial artery remodeling in response to shear stress increase within arteriovenous fistula for hemodialysis access. Endothelium 2003;10:95-102. (Pubitemid 36992269)
7. Dammers R, Tordoir JH, Kooman JP, Welten RJ, Hameleers JM, Kitslaar PJ, et al. The effect of flow changes on the arterial system proximal to an arteriovenous fistula for hemodialysis. Ultrasound Med Biol 2005;31:1327-33. (Pubitemid 41434048)
8. Remuzzi A, Ene-Iordache B, Mosconi L, Bruno S, Anghileri A, Antiga L, et al. Radial artery wall shear stress evaluation in patients with arteriovenous fistula for hemodialysis access. Biorheology 2003;40:423-30.
9. Forsten KE, Courant NA, Nugent MA. Endothelial proteoglycans inhibit bFGF binding and mitogenesis. J Cell Physiol 1997;172: 209-20. (Pubitemid 27339083)
10. Borrelli V, di Marzo L, Sapienza P, Colasanti M, Moroni E, Cavallaro A, et al. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions. Surgery 2006;140:454-63.
11. Conte MS, Nugent HM, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson JH, et al. Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. J Vasc Surg 2009;50:1359-68.
12. Center for Biologics Evaluation and Research, US Department of Health and Human Services, Food and Drug Administration. Points to consider in the characterization of cell line used to produce biologics. Silver Spring, MD: Food and Drug Administration; 1993.
13. Division of Human Tissues, Office of Cellular, Tissue and Gene Therapies, US Department of Health and Human Services, Food and Drug Administration. Guidance for industry: eligibility determination for donors of human cells, tissues and cellular and tissue-based products (HCT/Ps). Silver Spring, MD: Food and Drug Administration; 2007.
14. Biuckians A, Scott EC, Meier GH, Panneton JM, Glickman MH. The natural history of autologous fistulas as first-time dialysis access in the KDOQI era. J Vasc Surg 2008;47:415-21; discussion 420-11.
15. Patel ST, Hughes J, Mills JL, Sr. Failure of arteriovenous fistula maturation: an unintended consequence of exceeding dialysis outcome quality Initiative guidelines for hemodialysis access. J Vasc Surg 2003;38:439-45; discussion 445.
16. Asif A, Gadalean FN, Merrill D, Cherla G, Cipleu CD, Epstein DL, et al. Inflow stenosis in arteriovenous fistulas and grafts: a multicenter, prospective study. Kidney Intl 2005;67:1986-92. (Pubitemid 40577736)
17. Turmel-Rodrigues L, Pengloan J, Baudin S, Testou D, Abaza M, Dahdah G, et al. Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology. Nephrol Dial Transplant 2000;15:2029-36.
18. Tordoir JH, Rooyens P, Dammers R, van der Sande FM, de Haan M, Yo TI, et al. Prospective evaluation of failure modes in autogenous radiocephalic wrist access for haemodialysis. Nephrol Dial Transplant 2003;18:378-83. (Pubitemid 36181691)
19. Lauvao LS, Ihnat DM, Goshima KR, Chavez L, Gruessner AC, Mills JL Sr, et al. Vein diameter is the major predictor of fistula maturation. J Vasc Surg 2009;49:1499-504.
20. Gheith OA, Kamal MM. Risk factors of vascular access failure in patients on hemodialysis. Iranian J Kidney Diseases 2008;2:201-7.
21. Hammes M, Funaki B, Coe FL. Cephalic arch stenosis in patients with fistula access for hemodialysis: relationship to diabetes and thrombosis. Hemodialysis Intl 2008;12:85-9. (Pubitemid 351247383)
22. Broumand B. Diabetes: changing the fate of diabetics in the dialysis unit. Blood Purif 2007;25:39-47. (Pubitemid 46005750)
23. Ernandez T, Saudan P, Berney T, Merminod T, Bednarkiewicz M, Martin PY, et al. Risk factors for early failure of native arteriovenous fistulas. Nephron Clin Pract 2005;101:c39-44. (Pubitemid 41159943)
24. Murphy GJ, Nicholson ML. Autogeneous elbow fistulas: the effect of diabetes mellitus on maturation, patency, and complication rates. Eur J Vasc Endovasc Surg 2002;23:452-7. (Pubitemid 41079429)
25. Hayakawa K, Miyakawa S, Hoshinaga K, Hata K, Marumo K, Hata M, et al. The effect of patient age and other factors on the maintenance of permanent hemodialysis vascular access. Ther Apher Dial 2007;11:36-41.
26. Rask-Madsen C, King GL. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Practice 2007;3:46-56. (Pubitemid 46006612)
27. Sank A, Wei D, Reid J, Ertl D, Nimni M, Weaver F, et al. Human endothelial cells are defective in diabetic vascular disease. J Surg Res 1994;57:647-53.
28. Cohen RA, Tong X. Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. J Cadiovasc Pharcol 2010;55:308-16.
29. Kuroki T, Isshiki K, King GL. Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. J Am Soc Nephrol 2003;14:S216-220. (Pubitemid 36903928)
30. Ramasamy R, Yan SF, Schmidt AM. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Trends Cadiovasc Med 2005;15:237-43. (Pubitemid 41437905)
31. Roy-Chaudhury P, Kelly BS, Narayana A, Desai P, Melhem M, Munda R, et al. Hemodialysis vascular access dysfunction from basic biology to clinical intervention. Adv Ren Replace Ther 2002;9:74-84. (Pubitemid 35014290)
32. Hughes D, Fu AA, Puggioni A, Glockner JF, Anwer B, McGuire AM, et al. Adventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts alleviates hypoxia and decreases neointimal proliferation through a matrix metalloproteinase-9-mediated pathway-a pilot study. Nephrol Dial Transplant 2009;24:85-96.
33. Nugent HM, Groothuis A, Seifert P, Guerraro JL, Nedelman M, Mohanakumar T, et al. Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res 2002;39:524-33. (Pubitemid 36091843)
34. Wong V, Ward R, Taylor J, Selvakumar S, How TV, Bakran A, et al. Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur J Vasc Endovasc Surg 1996;12:207-13. (Pubitemid 26293579)
35. Corpataux JM, Haesler E, Silacci P, Ris HB, Hayoz D. Low-pressure environment and remodelling of the forearm vein in Brescia-Cimino haemodialysis access. Nephrol Dial Transplant 2002;17:1057-62. (Pubitemid 34746209)
36. Owens CD, Wake N, Kim JM, Hentschel D, Conte MS, Schanzer A, et al. Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease. J Vasc Access 2010;11:329-34.